CVS HEALTH Corp vs THE SHERWIN-WILLIAMS COMPANY, two Retail stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CVS and SHW diverge most: on return on equity, CVS reads 1.3% and SHW reads 69.7%; on net margin, CVS reads 0.2% and SHW reads 11.0%. The rest of the comparable metrics sit closer together. What CVS's price implies is a bet that sits within the historical range (whole-company basis). What SHW's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CVS | SHW |
|---|---|---|
| Price | $104.42 | $340.76 |
| Market cap | $133.6B | $83.8B |
| Sector | Retail | Retail |
| Stage | Mature | Mature |
| Implied growth (priced in) | — | +10.1% |
| P/E | — | 31.4 |
| P/B | 1.72 | 21.75 |
| P/S | 0.33 | 3.43 |
| EV/EBITDA | 17.5 | 253.0 |
| Revenue growth | +7.6% | +5.8% |
| Gross margin | — | 49.2% |
| Operating margin | 4.7% | — |
| Net margin | 0.2% | 11.0% |
| Return on equity | 1.3% | 69.7% |
| Return on assets | 0.4% | 10.0% |
| Return on invested capital | 3.2% | — |
| FCF yield | 5.5% | 3.8% |
| Dividend yield | 2.5% | 0.9% |
| Debt / equity | 0.78 | 3.13 |
| Current ratio | 0.87 | 0.73 |
| Altman Z (solvency) | 2.43 | 6.89 |
| Piotroski F (quality) | 6 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.